Vulnerabilities of the SARS-CoV-2 Virus to Proteotoxicity-Opportunity for Repurposed Chemotherapy of COVID-19 Infection

• Principais autores: Maryam S. Al-Motawa (Autor), Hafsa Abbas (Autor), Patrick Wijten (Autor), Alberto de la Fuente (Autor), Mingzhan Xue (Autor), Naila Rabbani (Autor), Paul J. Thornalley (Autor)
• Formato: Livro
• Publicado em: Frontiers Media S.A., 2020-10-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

The global pandemic of COVID-19 disease caused by infection with the SARS-CoV-2 coronavirus, has produced an urgent requirement and search for improved treatments while effective vaccines are developed. A strategy for improved drug therapy is to increase levels of endogenous reactive metabolites for...